Clinical Trial

Milk Thistle Clinical Trial in Pediatric NAFLD

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Pediatric Fatty Liver disease is a growing problem in the United States and is expected to be the leading cause of Liver Transplantation in Adults in 20 years. Following lifestyle changes such as diet restrictions and exercise may be difficult to consistently maintain. The purpose of this study is to investigate alternative medical therapy with an herbal supplement called Milk Thistle (MT) which may improve fatty liver disease and would be easier to follow than diet and exercise.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-06-20; most recent amendment 2026-01-23.
Status change: Not Yet Recruiting → Recruiting 2024-09-20
Trial Details
NCT Number NCT06477146
Lead Sponsor University Hospitals Cleveland Medical Center
Conditions Non-Alcoholic Fatty Liver Disease (NAFLD)
Enrollment 20 participants
Start Date 2024-12-19
Primary Completion 2029-01-31 (estimated)
Study Completion 2029-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-27